Our CEO, Mr. Hari Kiran Chereddi, has welcomed the government's progressive decision in the Union Budget 2025-26 to exempt Basic Customs Duty (BCD) on 36 life-saving drugs and extend concessional duty benefits to additional critical medicines.
"I wholeheartedly welcome the government's decision today to exempt Basic Customs Duty on 36 life-saving drugs and extend concessional duty benefits to additional critical medicines. This progressive move will significantly improve access to essential treatments for patients battling cancer, rare diseases, and other chronic conditions."
Mr. Hari Kiran Chereddi
Media Coverage
This important policy change has been covered extensively in : Express Pharma
The customs duty exemption reflects the government's commitment to enhancing healthcare affordability and accessibility, particularly for patients with severe conditions requiring specialized treatments.
